Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A holistic approach, including diet and stress management, may improve androgenetic alopecia treatment outcomes.

Most emerging dermatological treatments lack strong evidence and require more research.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

Researchers found that certain RNA circles in the brain are linked to disease risk, but their exact role in disease is still unknown.

New and repurposed treatments are improving outcomes in dermatology.

Integrating biological networks improves drug repurposing and ADR prediction.

Nanozymes show promise for effective and safe cancer treatment.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

Neural crest cells could be used in regenerative medicine due to their ability to become different cell types.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

New treatments for androgenetic alopecia show promise but need more research for validation.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Early diagnosis and personalized treatments are key to improving hair loss therapies.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.